Analysis of BMT CTN-0201 and -0901 samples did not reproduce the reported association between recipient REG3A rs7588571 and chronic GVHD

Armin Rashidi, Ryan Shanley, Claudio Anasetti, Edmund K. Waller, Bart L. Scott, Bruce R. Blazar, Daniel J. Weisdorf

Research output: Contribution to journalArticlepeer-review

Original languageEnglish (US)
Pages (from-to)490-493
Number of pages4
JournalBone marrow transplantation
Volume54
Issue number3
DOIs
StatePublished - Mar 1 2019

Bibliographical note

Funding Information:
Acknowledgements Support for the primary clinical trials was provided to the Blood and Marrow Transplant Clinical Trials Network by Grant #U10HL069294 from the National Heart, Lung, and Blood Institute and the National Cancer Institute. The Department of Navy, Office of Navy Research, and the National Marrow Donor Program also provided support. Enrollment support was provided by DKMS Germany. Research reported in this publication was also supported by NIH Grant P30 CA77598 utilizing the Biostatistics and Bioin-formatics Core shared resource of the Masonic Cancer Center, University of Minnesota and by the by the National Center for Advancing Translational Sciences of the National Institutes of Health Award Number UL1TR000114. Any views, opinions, findings, conclusions or recommendations expressed in this material are those of the author(s) and do not reflect the views or the official policy or position of the above-mentioned parties. Armin Rashidi was supported by an American Blood and Marrow Transplantation Young Investigator Award.

Cite this